Indeed, anti-IL-5 treatment, such as with an anti-IL-5 antibody (Ab) or an anti-IL-5R Ab, reduces the blood eosinophil count and asthma exacerbation frequency in patients with severe asthma with an increased blood eosinophil count [23]. Here, IL5 is linked to asthma.